IBDEI03P ; ; 01-AUG-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,8873,1,3,0)
;;=3^Hematuria,Microscopic,Asymptomatic
;;^UTILITY(U,$J,358.3,8873,1,4,0)
;;=4^R31.21
;;^UTILITY(U,$J,358.3,8873,2)
;;=^5139198
;;^UTILITY(U,$J,358.3,8874,0)
;;=R31.29^^45^428^59
;;^UTILITY(U,$J,358.3,8874,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8874,1,3,0)
;;=3^Hematuria,Microscopic,Other
;;^UTILITY(U,$J,358.3,8874,1,4,0)
;;=4^R31.29
;;^UTILITY(U,$J,358.3,8874,2)
;;=^5019327
;;^UTILITY(U,$J,358.3,8875,0)
;;=R39.198^^45^428^72
;;^UTILITY(U,$J,358.3,8875,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8875,1,3,0)
;;=3^Micturition,Oth Difficulties
;;^UTILITY(U,$J,358.3,8875,1,4,0)
;;=4^R39.198
;;^UTILITY(U,$J,358.3,8875,2)
;;=^5019347
;;^UTILITY(U,$J,358.3,8876,0)
;;=R39.191^^45^428^74
;;^UTILITY(U,$J,358.3,8876,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8876,1,3,0)
;;=3^Need to Immediately Re-Void
;;^UTILITY(U,$J,358.3,8876,1,4,0)
;;=4^R39.191
;;^UTILITY(U,$J,358.3,8876,2)
;;=^5139199
;;^UTILITY(U,$J,358.3,8877,0)
;;=R39.192^^45^428^73
;;^UTILITY(U,$J,358.3,8877,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8877,1,3,0)
;;=3^Micturition,Position Dependent
;;^UTILITY(U,$J,358.3,8877,1,4,0)
;;=4^R39.192
;;^UTILITY(U,$J,358.3,8877,2)
;;=^5139200
;;^UTILITY(U,$J,358.3,8878,0)
;;=R97.21^^45^428^103
;;^UTILITY(U,$J,358.3,8878,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8878,1,3,0)
;;=3^Rising PSA After Tx for Prostate CA
;;^UTILITY(U,$J,358.3,8878,1,4,0)
;;=4^R97.21
;;^UTILITY(U,$J,358.3,8878,2)
;;=^5139228
;;^UTILITY(U,$J,358.3,8879,0)
;;=N50.82^^45^428^104
;;^UTILITY(U,$J,358.3,8879,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8879,1,3,0)
;;=3^Scrotal Pain
;;^UTILITY(U,$J,358.3,8879,1,4,0)
;;=4^N50.82
;;^UTILITY(U,$J,358.3,8879,2)
;;=^5138930
;;^UTILITY(U,$J,358.3,8880,0)
;;=N50.812^^45^428^108
;;^UTILITY(U,$J,358.3,8880,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8880,1,3,0)
;;=3^Testicular Pain,Left Side
;;^UTILITY(U,$J,358.3,8880,1,4,0)
;;=4^N50.812
;;^UTILITY(U,$J,358.3,8880,2)
;;=^5138928
;;^UTILITY(U,$J,358.3,8881,0)
;;=N50.811^^45^428^109
;;^UTILITY(U,$J,358.3,8881,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8881,1,3,0)
;;=3^Testicular Pain,Right Side
;;^UTILITY(U,$J,358.3,8881,1,4,0)
;;=4^N50.811
;;^UTILITY(U,$J,358.3,8881,2)
;;=^5138927
;;^UTILITY(U,$J,358.3,8882,0)
;;=N35.919^^45^428^114
;;^UTILITY(U,$J,358.3,8882,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8882,1,3,0)
;;=3^Urethral Stricture,NOS,Male
;;^UTILITY(U,$J,358.3,8882,1,4,0)
;;=4^N35.919
;;^UTILITY(U,$J,358.3,8882,2)
;;=^5157412
;;^UTILITY(U,$J,358.3,8883,0)
;;=N35.92^^45^428^113
;;^UTILITY(U,$J,358.3,8883,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8883,1,3,0)
;;=3^Urethral Stricture,NOS,Female
;;^UTILITY(U,$J,358.3,8883,1,4,0)
;;=4^N35.92
;;^UTILITY(U,$J,358.3,8883,2)
;;=^5157413
;;^UTILITY(U,$J,358.3,8884,0)
;;=R82.81^^45^428^101
;;^UTILITY(U,$J,358.3,8884,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8884,1,3,0)
;;=3^Pyuria
;;^UTILITY(U,$J,358.3,8884,1,4,0)
;;=4^R82.81
;;^UTILITY(U,$J,358.3,8884,2)
;;=^101879
;;^UTILITY(U,$J,358.3,8885,0)
;;=N18.30^^45^428^17
;;^UTILITY(U,$J,358.3,8885,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8885,1,3,0)
;;=3^Chronic Kidney Disease,Stage 3 Unspec
;;^UTILITY(U,$J,358.3,8885,1,4,0)
;;=4^N18.30
;;^UTILITY(U,$J,358.3,8885,2)
;;=^5159286
;;^UTILITY(U,$J,358.3,8886,0)
;;=N18.31^^45^428^18
;;^UTILITY(U,$J,358.3,8886,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8886,1,3,0)
;;=3^Chronic Kidney Disease,Stage 3a
;;^UTILITY(U,$J,358.3,8886,1,4,0)
;;=4^N18.31
;;^UTILITY(U,$J,358.3,8886,2)
;;=^5159287
;;^UTILITY(U,$J,358.3,8887,0)
;;=N18.32^^45^428^19
;;^UTILITY(U,$J,358.3,8887,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8887,1,3,0)
;;=3^Chronic Kidney Disease,Stage 3b
;;^UTILITY(U,$J,358.3,8887,1,4,0)
;;=4^N18.32
;;^UTILITY(U,$J,358.3,8887,2)
;;=^5159288
;;^UTILITY(U,$J,358.3,8888,0)
;;=G44.1^^45^429^10
;;^UTILITY(U,$J,358.3,8888,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8888,1,3,0)
;;=3^Vascular Headache NEC
;;^UTILITY(U,$J,358.3,8888,1,4,0)
;;=4^G44.1
;;^UTILITY(U,$J,358.3,8888,2)
;;=^5003934
;;^UTILITY(U,$J,358.3,8889,0)
;;=G43.909^^45^429^6
;;^UTILITY(U,$J,358.3,8889,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8889,1,3,0)
;;=3^Migraine,Unspec,Not Intractable
;;^UTILITY(U,$J,358.3,8889,1,4,0)
;;=4^G43.909
;;^UTILITY(U,$J,358.3,8889,2)
;;=^5003909
;;^UTILITY(U,$J,358.3,8890,0)
;;=G44.009^^45^429^1
;;^UTILITY(U,$J,358.3,8890,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8890,1,3,0)
;;=3^Cluster Headache,Unspec,Not Intractable
;;^UTILITY(U,$J,358.3,8890,1,4,0)
;;=4^G44.009
;;^UTILITY(U,$J,358.3,8890,2)
;;=^5003921
;;^UTILITY(U,$J,358.3,8891,0)
;;=G44.40^^45^429^5
;;^UTILITY(U,$J,358.3,8891,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8891,1,3,0)
;;=3^Medication Overuse Headache,Not Intractable
;;^UTILITY(U,$J,358.3,8891,1,4,0)
;;=4^G44.40
;;^UTILITY(U,$J,358.3,8891,2)
;;=^5003947
;;^UTILITY(U,$J,358.3,8892,0)
;;=G44.89^^45^429^2
;;^UTILITY(U,$J,358.3,8892,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8892,1,3,0)
;;=3^Headache Syndrome NEC
;;^UTILITY(U,$J,358.3,8892,1,4,0)
;;=4^G44.89
;;^UTILITY(U,$J,358.3,8892,2)
;;=^5003954
;;^UTILITY(U,$J,358.3,8893,0)
;;=G44.84^^45^429^8
;;^UTILITY(U,$J,358.3,8893,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8893,1,3,0)
;;=3^Primary Exertional Headache
;;^UTILITY(U,$J,358.3,8893,1,4,0)
;;=4^G44.84
;;^UTILITY(U,$J,358.3,8893,2)
;;=^336563
;;^UTILITY(U,$J,358.3,8894,0)
;;=G44.301^^45^429^7
;;^UTILITY(U,$J,358.3,8894,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8894,1,3,0)
;;=3^Post-Traumatic Headache,Unspec,Intractable
;;^UTILITY(U,$J,358.3,8894,1,4,0)
;;=4^G44.301
;;^UTILITY(U,$J,358.3,8894,2)
;;=^5003941
;;^UTILITY(U,$J,358.3,8895,0)
;;=G44.209^^45^429^9
;;^UTILITY(U,$J,358.3,8895,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8895,1,3,0)
;;=3^Tension-Type Headache,Unspec,Not Intractable
;;^UTILITY(U,$J,358.3,8895,1,4,0)
;;=4^G44.209
;;^UTILITY(U,$J,358.3,8895,2)
;;=^5003936
;;^UTILITY(U,$J,358.3,8896,0)
;;=R51.0^^45^429^3
;;^UTILITY(U,$J,358.3,8896,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8896,1,3,0)
;;=3^Headache w/ Orthostatic Component,NEC
;;^UTILITY(U,$J,358.3,8896,1,4,0)
;;=4^R51.0
;;^UTILITY(U,$J,358.3,8896,2)
;;=^5159305
;;^UTILITY(U,$J,358.3,8897,0)
;;=R51.9^^45^429^4
;;^UTILITY(U,$J,358.3,8897,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8897,1,3,0)
;;=3^Headache,Unspec
;;^UTILITY(U,$J,358.3,8897,1,4,0)
;;=4^R51.9
;;^UTILITY(U,$J,358.3,8897,2)
;;=^5159306
;;^UTILITY(U,$J,358.3,8898,0)
;;=I30.0^^45^430^5
;;^UTILITY(U,$J,358.3,8898,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8898,1,3,0)
;;=3^Idiopathic Pericarditis,Acute Nonspec
;;^UTILITY(U,$J,358.3,8898,1,4,0)
;;=4^I30.0
;;^UTILITY(U,$J,358.3,8898,2)
;;=^5007157
;;^UTILITY(U,$J,358.3,8899,0)
;;=I34.8^^45^430^6
;;^UTILITY(U,$J,358.3,8899,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8899,1,3,0)
;;=3^Mitral Valve Disorders,Nonrheumatic Other
;;^UTILITY(U,$J,358.3,8899,1,4,0)
;;=4^I34.8
;;^UTILITY(U,$J,358.3,8899,2)
;;=^5007172
;;^UTILITY(U,$J,358.3,8900,0)
;;=I34.0^^45^430^13
;;^UTILITY(U,$J,358.3,8900,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8900,1,3,0)
;;=3^Nonrheumatic Mitral Valve Insufficiency
;;^UTILITY(U,$J,358.3,8900,1,4,0)
;;=4^I34.0
;;^UTILITY(U,$J,358.3,8900,2)
;;=^5007169
;;^UTILITY(U,$J,358.3,8901,0)
;;=I34.9^^45^430^12
;;^UTILITY(U,$J,358.3,8901,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8901,1,3,0)
;;=3^Nonrheumatic Mitral Valve Disorder,Unspec
;;^UTILITY(U,$J,358.3,8901,1,4,0)
;;=4^I34.9
;;^UTILITY(U,$J,358.3,8901,2)
;;=^5007173
;;^UTILITY(U,$J,358.3,8902,0)
;;=I34.2^^45^430^7
;;^UTILITY(U,$J,358.3,8902,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8902,1,3,0)
;;=3^Nonrhematic Mitral Valve Stenosis
;;^UTILITY(U,$J,358.3,8902,1,4,0)
;;=4^I34.2
;;^UTILITY(U,$J,358.3,8902,2)
;;=^5007171
;;^UTILITY(U,$J,358.3,8903,0)
;;=I35.0^^45^430^10
;;^UTILITY(U,$J,358.3,8903,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8903,1,3,0)
;;=3^Nonrheumatic Aortic Valve Stenosis
;;^UTILITY(U,$J,358.3,8903,1,4,0)
;;=4^I35.0
;;^UTILITY(U,$J,358.3,8903,2)
;;=^5007174
;;^UTILITY(U,$J,358.3,8904,0)
;;=I35.1^^45^430^9
;;^UTILITY(U,$J,358.3,8904,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8904,1,3,0)
;;=3^Nonrheumatic Aortic Valve Insufficiency
;;^UTILITY(U,$J,358.3,8904,1,4,0)
;;=4^I35.1
;;^UTILITY(U,$J,358.3,8904,2)
;;=^5007175
;;^UTILITY(U,$J,358.3,8905,0)
;;=I35.2^^45^430^11
;;^UTILITY(U,$J,358.3,8905,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8905,1,3,0)
;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
;;^UTILITY(U,$J,358.3,8905,1,4,0)
;;=4^I35.2
;;^UTILITY(U,$J,358.3,8905,2)
;;=^5007176
;;^UTILITY(U,$J,358.3,8906,0)
;;=I35.9^^45^430^8
;;^UTILITY(U,$J,358.3,8906,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8906,1,3,0)
;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
;;^UTILITY(U,$J,358.3,8906,1,4,0)
;;=4^I35.9
;;^UTILITY(U,$J,358.3,8906,2)
;;=^5007178
;;^UTILITY(U,$J,358.3,8907,0)
;;=I38.^^45^430^4
;;^UTILITY(U,$J,358.3,8907,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8907,1,3,0)
;;=3^Endocarditis,Valve Unspec
;;^UTILITY(U,$J,358.3,8907,1,4,0)
;;=4^I38.
;;^UTILITY(U,$J,358.3,8907,2)
;;=^40327
;;^UTILITY(U,$J,358.3,8908,0)
;;=I05.0^^45^430^18
;;^UTILITY(U,$J,358.3,8908,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8908,1,3,0)
;;=3^Rheumatic Mitral Stenosis
;;^UTILITY(U,$J,358.3,8908,1,4,0)
;;=4^I05.0
;;^UTILITY(U,$J,358.3,8908,2)
;;=^5007041
;;^UTILITY(U,$J,358.3,8909,0)
;;=I05.8^^45^430^19
;;^UTILITY(U,$J,358.3,8909,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8909,1,3,0)
;;=3^Rheumatic Mitral Valve Disease NEC
;;^UTILITY(U,$J,358.3,8909,1,4,0)
;;=4^I05.8
;;^UTILITY(U,$J,358.3,8909,2)
;;=^5007043
;;^UTILITY(U,$J,358.3,8910,0)
;;=I05.9^^45^430^20
;;^UTILITY(U,$J,358.3,8910,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8910,1,3,0)
;;=3^Rheumatic Mitral Valve Disease,Unspec
;;^UTILITY(U,$J,358.3,8910,1,4,0)
;;=4^I05.9
;;^UTILITY(U,$J,358.3,8910,2)
;;=^5007044
;;^UTILITY(U,$J,358.3,8911,0)
;;=I07.1^^45^430^21
;;^UTILITY(U,$J,358.3,8911,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8911,1,3,0)
;;=3^Rheumatic Tricuspid Insufficiency
;;^UTILITY(U,$J,358.3,8911,1,4,0)
;;=4^I07.1
;;^UTILITY(U,$J,358.3,8911,2)
;;=^5007048
;;^UTILITY(U,$J,358.3,8912,0)
;;=I07.9^^45^430^22
;;^UTILITY(U,$J,358.3,8912,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8912,1,3,0)
;;=3^Rheumatic Tricuspid Valve Disease,Unspec
;;^UTILITY(U,$J,358.3,8912,1,4,0)
;;=4^I07.9
;;^UTILITY(U,$J,358.3,8912,2)
;;=^5007051
;;^UTILITY(U,$J,358.3,8913,0)
;;=I08.0^^45^430^16
;;^UTILITY(U,$J,358.3,8913,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8913,1,3,0)
;;=3^Rheumatic Disorders of Mitral & Aortic Valves
;;^UTILITY(U,$J,358.3,8913,1,4,0)
;;=4^I08.0
;;^UTILITY(U,$J,358.3,8913,2)
;;=^5007052
;;^UTILITY(U,$J,358.3,8914,0)
;;=I09.89^^45^430^17
;;^UTILITY(U,$J,358.3,8914,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8914,1,3,0)
;;=3^Rheumatic Heart Diseases NEC
;;^UTILITY(U,$J,358.3,8914,1,4,0)
;;=4^I09.89
;;^UTILITY(U,$J,358.3,8914,2)
;;=^5007060
;;^UTILITY(U,$J,358.3,8915,0)
;;=I47.1^^45^430^24
;;^UTILITY(U,$J,358.3,8915,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8915,1,3,0)
;;=3^Supraventricular Tachycardia
;;^UTILITY(U,$J,358.3,8915,1,4,0)
;;=4^I47.1
;;^UTILITY(U,$J,358.3,8915,2)
;;=^5007223
;;^UTILITY(U,$J,358.3,8916,0)
;;=I48.0^^45^430^15
;;^UTILITY(U,$J,358.3,8916,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8916,1,3,0)
;;=3^Paroxysmal Atrial Fibrillation
;;^UTILITY(U,$J,358.3,8916,1,4,0)
;;=4^I48.0
;;^UTILITY(U,$J,358.3,8916,2)
;;=^90473
;;^UTILITY(U,$J,358.3,8917,0)
;;=I49.5^^45^430^23
;;^UTILITY(U,$J,358.3,8917,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8917,1,3,0)
;;=3^Sick Sinus Syndrome
;;^UTILITY(U,$J,358.3,8917,1,4,0)
;;=4^I49.5
;;^UTILITY(U,$J,358.3,8917,2)
;;=^110404
;;^UTILITY(U,$J,358.3,8918,0)
;;=I49.8^^45^430^3
;;^UTILITY(U,$J,358.3,8918,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8918,1,3,0)
;;=3^Cardiac Arrhythmias
;;^UTILITY(U,$J,358.3,8918,1,4,0)
;;=4^I49.8
;;^UTILITY(U,$J,358.3,8918,2)
;;=^5007236
;;^UTILITY(U,$J,358.3,8919,0)
;;=I49.9^^45^430^2
;;^UTILITY(U,$J,358.3,8919,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8919,1,3,0)
;;=3^Cardiac Arrhythmia,Unspec
;;^UTILITY(U,$J,358.3,8919,1,4,0)
;;=4^I49.9
;;^UTILITY(U,$J,358.3,8919,2)
;;=^5007237
;;^UTILITY(U,$J,358.3,8920,0)
;;=R00.1^^45^430^1
;;^UTILITY(U,$J,358.3,8920,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8920,1,3,0)
;;=3^Bradycardia,Unspec
;;^UTILITY(U,$J,358.3,8920,1,4,0)
;;=4^R00.1
;;^UTILITY(U,$J,358.3,8920,2)
;;=^5019164
;;^UTILITY(U,$J,358.3,8921,0)
;;=I34.1^^45^430^14
;;^UTILITY(U,$J,358.3,8921,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8921,1,3,0)
;;=3^Nonrheumatic Mitral Valve Prolapse
;;^UTILITY(U,$J,358.3,8921,1,4,0)
;;=4^I34.1
;;^UTILITY(U,$J,358.3,8921,2)
;;=^5007170
;;^UTILITY(U,$J,358.3,8922,0)
;;=D68.4^^45^431^1
;;^UTILITY(U,$J,358.3,8922,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8922,1,3,0)
;;=3^Acquired Coagulation Factor Deficiency
;;^UTILITY(U,$J,358.3,8922,1,4,0)
;;=4^D68.4
;;^UTILITY(U,$J,358.3,8922,2)
;;=^2235
;;^UTILITY(U,$J,358.3,8923,0)
;;=D59.9^^45^431^2
;;^UTILITY(U,$J,358.3,8923,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8923,1,3,0)
;;=3^Acquired Hemolytic Anemia,Unspec
;;^UTILITY(U,$J,358.3,8923,1,4,0)
;;=4^D59.9
;;^UTILITY(U,$J,358.3,8923,2)
;;=^5002330
;;^UTILITY(U,$J,358.3,8924,0)
;;=C91.00^^45^431^5
;;^UTILITY(U,$J,358.3,8924,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8924,1,3,0)
;;=3^Acute Lymphoblastic Leukemia,Not in Remission
;;^UTILITY(U,$J,358.3,8924,1,4,0)
;;=4^C91.00
;;^UTILITY(U,$J,358.3,8924,2)
;;=^5001762
;;^UTILITY(U,$J,358.3,8925,0)
;;=C91.01^^45^431^4
;;^UTILITY(U,$J,358.3,8925,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8925,1,3,0)
;;=3^Acute Lymphoblastic Leukemia,In Remission
;;^UTILITY(U,$J,358.3,8925,1,4,0)
;;=4^C91.01
;;^UTILITY(U,$J,358.3,8925,2)
;;=^5001763
;;^UTILITY(U,$J,358.3,8926,0)
;;=C92.01^^45^431^7
;;^UTILITY(U,$J,358.3,8926,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8926,1,3,0)
;;=3^Acute Myeloblastic Leukemia,In Remission
;;^UTILITY(U,$J,358.3,8926,1,4,0)
;;=4^C92.01
;;^UTILITY(U,$J,358.3,8926,2)
;;=^5001790
;;^UTILITY(U,$J,358.3,8927,0)
;;=C92.00^^45^431^8
;;^UTILITY(U,$J,358.3,8927,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8927,1,3,0)
;;=3^Acute Myeloblastic Leukemia,Not in Remission
;;^UTILITY(U,$J,358.3,8927,1,4,0)
;;=4^C92.00
;;^UTILITY(U,$J,358.3,8927,2)
;;=^5001789
;;^UTILITY(U,$J,358.3,8928,0)
;;=C92.61^^45^431^9
;;^UTILITY(U,$J,358.3,8928,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8928,1,3,0)
;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,In Remission
;;^UTILITY(U,$J,358.3,8928,1,4,0)
;;=4^C92.61
;;^UTILITY(U,$J,358.3,8928,2)
;;=^5001808
;;^UTILITY(U,$J,358.3,8929,0)
;;=C92.60^^45^431^10
;;^UTILITY(U,$J,358.3,8929,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8929,1,3,0)
;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,Not in Remission
;;^UTILITY(U,$J,358.3,8929,1,4,0)
;;=4^C92.60
;;^UTILITY(U,$J,358.3,8929,2)
;;=^5001807
;;^UTILITY(U,$J,358.3,8930,0)
;;=C92.A1^^45^431^11
;;^UTILITY(U,$J,358.3,8930,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8930,1,3,0)
;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,In Remission
;;^UTILITY(U,$J,358.3,8930,1,4,0)
;;=4^C92.A1
;;^UTILITY(U,$J,358.3,8930,2)
;;=^5001814
;;^UTILITY(U,$J,358.3,8931,0)
;;=C92.A0^^45^431^12
;;^UTILITY(U,$J,358.3,8931,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8931,1,3,0)
;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,Not in Remission
;;^UTILITY(U,$J,358.3,8931,1,4,0)
;;=4^C92.A0
;;^UTILITY(U,$J,358.3,8931,2)
;;=^5001813
;;^UTILITY(U,$J,358.3,8932,0)
;;=C92.51^^45^431^13
;;^UTILITY(U,$J,358.3,8932,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8932,1,3,0)
;;=3^Acute Myelomonocytic Leukemia,In Remission
;;^UTILITY(U,$J,358.3,8932,1,4,0)
;;=4^C92.51
;;^UTILITY(U,$J,358.3,8932,2)
;;=^5001805
;;^UTILITY(U,$J,358.3,8933,0)
;;=C92.50^^45^431^14
;;^UTILITY(U,$J,358.3,8933,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8933,1,3,0)
;;=3^Acute Myelomonocytic Leukemia,Not in Remission
;;^UTILITY(U,$J,358.3,8933,1,4,0)
;;=4^C92.50
;;^UTILITY(U,$J,358.3,8933,2)
;;=^5001804
;;^UTILITY(U,$J,358.3,8934,0)
;;=C94.40^^45^431^17
;;^UTILITY(U,$J,358.3,8934,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8934,1,3,0)
;;=3^Acute Panmyelosis w/ Myelofibrosis,Not in Remission
;;^UTILITY(U,$J,358.3,8934,1,4,0)
;;=4^C94.40
;;^UTILITY(U,$J,358.3,8934,2)
;;=^5001843
;;^UTILITY(U,$J,358.3,8935,0)
;;=C94.42^^45^431^15
;;^UTILITY(U,$J,358.3,8935,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8935,1,3,0)
;;=3^Acute Panmyelosis w/ Myelofibrosis,In Relapse
;;^UTILITY(U,$J,358.3,8935,1,4,0)
;;=4^C94.42
;;^UTILITY(U,$J,358.3,8935,2)
;;=^5001845
;;^UTILITY(U,$J,358.3,8936,0)
;;=C94.41^^45^431^16
;;^UTILITY(U,$J,358.3,8936,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8936,1,3,0)
;;=3^Acute Panmyelosis w/ Myelofibrosis,In Remission
;;^UTILITY(U,$J,358.3,8936,1,4,0)
;;=4^C94.41
;;^UTILITY(U,$J,358.3,8936,2)
;;=^5001844
;;^UTILITY(U,$J,358.3,8937,0)
;;=D62.^^45^431^18
;;^UTILITY(U,$J,358.3,8937,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8937,1,3,0)
;;=3^Acute Posthemorrhagic Anemia
;;^UTILITY(U,$J,358.3,8937,1,4,0)
;;=4^D62.
;;^UTILITY(U,$J,358.3,8937,2)
;;=^267986
;;^UTILITY(U,$J,358.3,8938,0)
;;=C92.41^^45^431^19
;;^UTILITY(U,$J,358.3,8938,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8938,1,3,0)
;;=3^Acute Promyelocytic Leukemia,In Remission
;;^UTILITY(U,$J,358.3,8938,1,4,0)
;;=4^C92.41
;;^UTILITY(U,$J,358.3,8938,2)
;;=^5001802
;;^UTILITY(U,$J,358.3,8939,0)
;;=C92.40^^45^431^20
;;^UTILITY(U,$J,358.3,8939,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8939,1,3,0)
;;=3^Acute Promyelocytic Leukemia,Not in Remission
;;^UTILITY(U,$J,358.3,8939,1,4,0)
;;=4^C92.40
;;^UTILITY(U,$J,358.3,8939,2)
;;=^5001801
;;^UTILITY(U,$J,358.3,8940,0)
;;=D56.0^^45^431^21
;;^UTILITY(U,$J,358.3,8940,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8940,1,3,0)
;;=3^Alpha Thalassemia
;;^UTILITY(U,$J,358.3,8940,1,4,0)
;;=4^D56.0
;;^UTILITY(U,$J,358.3,8940,2)
;;=^340494
;;^UTILITY(U,$J,358.3,8941,0)
;;=D63.1^^45^431^23
;;^UTILITY(U,$J,358.3,8941,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8941,1,3,0)
;;=3^Anemia in Chronic Kidney Disease
;;^UTILITY(U,$J,358.3,8941,1,4,0)
;;=4^D63.1
;;^UTILITY(U,$J,358.3,8941,2)
;;=^332908
;;^UTILITY(U,$J,358.3,8942,0)
;;=D63.0^^45^431^24
;;^UTILITY(U,$J,358.3,8942,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8942,1,3,0)
;;=3^Anemia in Neoplastic Disease
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI03P 19751 printed Nov 22, 2024@16:51:13 Page 2
IBDEI03P ; ; 01-AUG-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,8873,1,3,0)
+2 ;;=3^Hematuria,Microscopic,Asymptomatic
+3 ;;^UTILITY(U,$J,358.3,8873,1,4,0)
+4 ;;=4^R31.21
+5 ;;^UTILITY(U,$J,358.3,8873,2)
+6 ;;=^5139198
+7 ;;^UTILITY(U,$J,358.3,8874,0)
+8 ;;=R31.29^^45^428^59
+9 ;;^UTILITY(U,$J,358.3,8874,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,8874,1,3,0)
+12 ;;=3^Hematuria,Microscopic,Other
+13 ;;^UTILITY(U,$J,358.3,8874,1,4,0)
+14 ;;=4^R31.29
+15 ;;^UTILITY(U,$J,358.3,8874,2)
+16 ;;=^5019327
+17 ;;^UTILITY(U,$J,358.3,8875,0)
+18 ;;=R39.198^^45^428^72
+19 ;;^UTILITY(U,$J,358.3,8875,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,8875,1,3,0)
+22 ;;=3^Micturition,Oth Difficulties
+23 ;;^UTILITY(U,$J,358.3,8875,1,4,0)
+24 ;;=4^R39.198
+25 ;;^UTILITY(U,$J,358.3,8875,2)
+26 ;;=^5019347
+27 ;;^UTILITY(U,$J,358.3,8876,0)
+28 ;;=R39.191^^45^428^74
+29 ;;^UTILITY(U,$J,358.3,8876,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,8876,1,3,0)
+32 ;;=3^Need to Immediately Re-Void
+33 ;;^UTILITY(U,$J,358.3,8876,1,4,0)
+34 ;;=4^R39.191
+35 ;;^UTILITY(U,$J,358.3,8876,2)
+36 ;;=^5139199
+37 ;;^UTILITY(U,$J,358.3,8877,0)
+38 ;;=R39.192^^45^428^73
+39 ;;^UTILITY(U,$J,358.3,8877,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,8877,1,3,0)
+42 ;;=3^Micturition,Position Dependent
+43 ;;^UTILITY(U,$J,358.3,8877,1,4,0)
+44 ;;=4^R39.192
+45 ;;^UTILITY(U,$J,358.3,8877,2)
+46 ;;=^5139200
+47 ;;^UTILITY(U,$J,358.3,8878,0)
+48 ;;=R97.21^^45^428^103
+49 ;;^UTILITY(U,$J,358.3,8878,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,8878,1,3,0)
+52 ;;=3^Rising PSA After Tx for Prostate CA
+53 ;;^UTILITY(U,$J,358.3,8878,1,4,0)
+54 ;;=4^R97.21
+55 ;;^UTILITY(U,$J,358.3,8878,2)
+56 ;;=^5139228
+57 ;;^UTILITY(U,$J,358.3,8879,0)
+58 ;;=N50.82^^45^428^104
+59 ;;^UTILITY(U,$J,358.3,8879,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,8879,1,3,0)
+62 ;;=3^Scrotal Pain
+63 ;;^UTILITY(U,$J,358.3,8879,1,4,0)
+64 ;;=4^N50.82
+65 ;;^UTILITY(U,$J,358.3,8879,2)
+66 ;;=^5138930
+67 ;;^UTILITY(U,$J,358.3,8880,0)
+68 ;;=N50.812^^45^428^108
+69 ;;^UTILITY(U,$J,358.3,8880,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,8880,1,3,0)
+72 ;;=3^Testicular Pain,Left Side
+73 ;;^UTILITY(U,$J,358.3,8880,1,4,0)
+74 ;;=4^N50.812
+75 ;;^UTILITY(U,$J,358.3,8880,2)
+76 ;;=^5138928
+77 ;;^UTILITY(U,$J,358.3,8881,0)
+78 ;;=N50.811^^45^428^109
+79 ;;^UTILITY(U,$J,358.3,8881,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,8881,1,3,0)
+82 ;;=3^Testicular Pain,Right Side
+83 ;;^UTILITY(U,$J,358.3,8881,1,4,0)
+84 ;;=4^N50.811
+85 ;;^UTILITY(U,$J,358.3,8881,2)
+86 ;;=^5138927
+87 ;;^UTILITY(U,$J,358.3,8882,0)
+88 ;;=N35.919^^45^428^114
+89 ;;^UTILITY(U,$J,358.3,8882,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,8882,1,3,0)
+92 ;;=3^Urethral Stricture,NOS,Male
+93 ;;^UTILITY(U,$J,358.3,8882,1,4,0)
+94 ;;=4^N35.919
+95 ;;^UTILITY(U,$J,358.3,8882,2)
+96 ;;=^5157412
+97 ;;^UTILITY(U,$J,358.3,8883,0)
+98 ;;=N35.92^^45^428^113
+99 ;;^UTILITY(U,$J,358.3,8883,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,8883,1,3,0)
+102 ;;=3^Urethral Stricture,NOS,Female
+103 ;;^UTILITY(U,$J,358.3,8883,1,4,0)
+104 ;;=4^N35.92
+105 ;;^UTILITY(U,$J,358.3,8883,2)
+106 ;;=^5157413
+107 ;;^UTILITY(U,$J,358.3,8884,0)
+108 ;;=R82.81^^45^428^101
+109 ;;^UTILITY(U,$J,358.3,8884,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,8884,1,3,0)
+112 ;;=3^Pyuria
+113 ;;^UTILITY(U,$J,358.3,8884,1,4,0)
+114 ;;=4^R82.81
+115 ;;^UTILITY(U,$J,358.3,8884,2)
+116 ;;=^101879
+117 ;;^UTILITY(U,$J,358.3,8885,0)
+118 ;;=N18.30^^45^428^17
+119 ;;^UTILITY(U,$J,358.3,8885,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,8885,1,3,0)
+122 ;;=3^Chronic Kidney Disease,Stage 3 Unspec
+123 ;;^UTILITY(U,$J,358.3,8885,1,4,0)
+124 ;;=4^N18.30
+125 ;;^UTILITY(U,$J,358.3,8885,2)
+126 ;;=^5159286
+127 ;;^UTILITY(U,$J,358.3,8886,0)
+128 ;;=N18.31^^45^428^18
+129 ;;^UTILITY(U,$J,358.3,8886,1,0)
+130 ;;=^358.31IA^4^2
+131 ;;^UTILITY(U,$J,358.3,8886,1,3,0)
+132 ;;=3^Chronic Kidney Disease,Stage 3a
+133 ;;^UTILITY(U,$J,358.3,8886,1,4,0)
+134 ;;=4^N18.31
+135 ;;^UTILITY(U,$J,358.3,8886,2)
+136 ;;=^5159287
+137 ;;^UTILITY(U,$J,358.3,8887,0)
+138 ;;=N18.32^^45^428^19
+139 ;;^UTILITY(U,$J,358.3,8887,1,0)
+140 ;;=^358.31IA^4^2
+141 ;;^UTILITY(U,$J,358.3,8887,1,3,0)
+142 ;;=3^Chronic Kidney Disease,Stage 3b
+143 ;;^UTILITY(U,$J,358.3,8887,1,4,0)
+144 ;;=4^N18.32
+145 ;;^UTILITY(U,$J,358.3,8887,2)
+146 ;;=^5159288
+147 ;;^UTILITY(U,$J,358.3,8888,0)
+148 ;;=G44.1^^45^429^10
+149 ;;^UTILITY(U,$J,358.3,8888,1,0)
+150 ;;=^358.31IA^4^2
+151 ;;^UTILITY(U,$J,358.3,8888,1,3,0)
+152 ;;=3^Vascular Headache NEC
+153 ;;^UTILITY(U,$J,358.3,8888,1,4,0)
+154 ;;=4^G44.1
+155 ;;^UTILITY(U,$J,358.3,8888,2)
+156 ;;=^5003934
+157 ;;^UTILITY(U,$J,358.3,8889,0)
+158 ;;=G43.909^^45^429^6
+159 ;;^UTILITY(U,$J,358.3,8889,1,0)
+160 ;;=^358.31IA^4^2
+161 ;;^UTILITY(U,$J,358.3,8889,1,3,0)
+162 ;;=3^Migraine,Unspec,Not Intractable
+163 ;;^UTILITY(U,$J,358.3,8889,1,4,0)
+164 ;;=4^G43.909
+165 ;;^UTILITY(U,$J,358.3,8889,2)
+166 ;;=^5003909
+167 ;;^UTILITY(U,$J,358.3,8890,0)
+168 ;;=G44.009^^45^429^1
+169 ;;^UTILITY(U,$J,358.3,8890,1,0)
+170 ;;=^358.31IA^4^2
+171 ;;^UTILITY(U,$J,358.3,8890,1,3,0)
+172 ;;=3^Cluster Headache,Unspec,Not Intractable
+173 ;;^UTILITY(U,$J,358.3,8890,1,4,0)
+174 ;;=4^G44.009
+175 ;;^UTILITY(U,$J,358.3,8890,2)
+176 ;;=^5003921
+177 ;;^UTILITY(U,$J,358.3,8891,0)
+178 ;;=G44.40^^45^429^5
+179 ;;^UTILITY(U,$J,358.3,8891,1,0)
+180 ;;=^358.31IA^4^2
+181 ;;^UTILITY(U,$J,358.3,8891,1,3,0)
+182 ;;=3^Medication Overuse Headache,Not Intractable
+183 ;;^UTILITY(U,$J,358.3,8891,1,4,0)
+184 ;;=4^G44.40
+185 ;;^UTILITY(U,$J,358.3,8891,2)
+186 ;;=^5003947
+187 ;;^UTILITY(U,$J,358.3,8892,0)
+188 ;;=G44.89^^45^429^2
+189 ;;^UTILITY(U,$J,358.3,8892,1,0)
+190 ;;=^358.31IA^4^2
+191 ;;^UTILITY(U,$J,358.3,8892,1,3,0)
+192 ;;=3^Headache Syndrome NEC
+193 ;;^UTILITY(U,$J,358.3,8892,1,4,0)
+194 ;;=4^G44.89
+195 ;;^UTILITY(U,$J,358.3,8892,2)
+196 ;;=^5003954
+197 ;;^UTILITY(U,$J,358.3,8893,0)
+198 ;;=G44.84^^45^429^8
+199 ;;^UTILITY(U,$J,358.3,8893,1,0)
+200 ;;=^358.31IA^4^2
+201 ;;^UTILITY(U,$J,358.3,8893,1,3,0)
+202 ;;=3^Primary Exertional Headache
+203 ;;^UTILITY(U,$J,358.3,8893,1,4,0)
+204 ;;=4^G44.84
+205 ;;^UTILITY(U,$J,358.3,8893,2)
+206 ;;=^336563
+207 ;;^UTILITY(U,$J,358.3,8894,0)
+208 ;;=G44.301^^45^429^7
+209 ;;^UTILITY(U,$J,358.3,8894,1,0)
+210 ;;=^358.31IA^4^2
+211 ;;^UTILITY(U,$J,358.3,8894,1,3,0)
+212 ;;=3^Post-Traumatic Headache,Unspec,Intractable
+213 ;;^UTILITY(U,$J,358.3,8894,1,4,0)
+214 ;;=4^G44.301
+215 ;;^UTILITY(U,$J,358.3,8894,2)
+216 ;;=^5003941
+217 ;;^UTILITY(U,$J,358.3,8895,0)
+218 ;;=G44.209^^45^429^9
+219 ;;^UTILITY(U,$J,358.3,8895,1,0)
+220 ;;=^358.31IA^4^2
+221 ;;^UTILITY(U,$J,358.3,8895,1,3,0)
+222 ;;=3^Tension-Type Headache,Unspec,Not Intractable
+223 ;;^UTILITY(U,$J,358.3,8895,1,4,0)
+224 ;;=4^G44.209
+225 ;;^UTILITY(U,$J,358.3,8895,2)
+226 ;;=^5003936
+227 ;;^UTILITY(U,$J,358.3,8896,0)
+228 ;;=R51.0^^45^429^3
+229 ;;^UTILITY(U,$J,358.3,8896,1,0)
+230 ;;=^358.31IA^4^2
+231 ;;^UTILITY(U,$J,358.3,8896,1,3,0)
+232 ;;=3^Headache w/ Orthostatic Component,NEC
+233 ;;^UTILITY(U,$J,358.3,8896,1,4,0)
+234 ;;=4^R51.0
+235 ;;^UTILITY(U,$J,358.3,8896,2)
+236 ;;=^5159305
+237 ;;^UTILITY(U,$J,358.3,8897,0)
+238 ;;=R51.9^^45^429^4
+239 ;;^UTILITY(U,$J,358.3,8897,1,0)
+240 ;;=^358.31IA^4^2
+241 ;;^UTILITY(U,$J,358.3,8897,1,3,0)
+242 ;;=3^Headache,Unspec
+243 ;;^UTILITY(U,$J,358.3,8897,1,4,0)
+244 ;;=4^R51.9
+245 ;;^UTILITY(U,$J,358.3,8897,2)
+246 ;;=^5159306
+247 ;;^UTILITY(U,$J,358.3,8898,0)
+248 ;;=I30.0^^45^430^5
+249 ;;^UTILITY(U,$J,358.3,8898,1,0)
+250 ;;=^358.31IA^4^2
+251 ;;^UTILITY(U,$J,358.3,8898,1,3,0)
+252 ;;=3^Idiopathic Pericarditis,Acute Nonspec
+253 ;;^UTILITY(U,$J,358.3,8898,1,4,0)
+254 ;;=4^I30.0
+255 ;;^UTILITY(U,$J,358.3,8898,2)
+256 ;;=^5007157
+257 ;;^UTILITY(U,$J,358.3,8899,0)
+258 ;;=I34.8^^45^430^6
+259 ;;^UTILITY(U,$J,358.3,8899,1,0)
+260 ;;=^358.31IA^4^2
+261 ;;^UTILITY(U,$J,358.3,8899,1,3,0)
+262 ;;=3^Mitral Valve Disorders,Nonrheumatic Other
+263 ;;^UTILITY(U,$J,358.3,8899,1,4,0)
+264 ;;=4^I34.8
+265 ;;^UTILITY(U,$J,358.3,8899,2)
+266 ;;=^5007172
+267 ;;^UTILITY(U,$J,358.3,8900,0)
+268 ;;=I34.0^^45^430^13
+269 ;;^UTILITY(U,$J,358.3,8900,1,0)
+270 ;;=^358.31IA^4^2
+271 ;;^UTILITY(U,$J,358.3,8900,1,3,0)
+272 ;;=3^Nonrheumatic Mitral Valve Insufficiency
+273 ;;^UTILITY(U,$J,358.3,8900,1,4,0)
+274 ;;=4^I34.0
+275 ;;^UTILITY(U,$J,358.3,8900,2)
+276 ;;=^5007169
+277 ;;^UTILITY(U,$J,358.3,8901,0)
+278 ;;=I34.9^^45^430^12
+279 ;;^UTILITY(U,$J,358.3,8901,1,0)
+280 ;;=^358.31IA^4^2
+281 ;;^UTILITY(U,$J,358.3,8901,1,3,0)
+282 ;;=3^Nonrheumatic Mitral Valve Disorder,Unspec
+283 ;;^UTILITY(U,$J,358.3,8901,1,4,0)
+284 ;;=4^I34.9
+285 ;;^UTILITY(U,$J,358.3,8901,2)
+286 ;;=^5007173
+287 ;;^UTILITY(U,$J,358.3,8902,0)
+288 ;;=I34.2^^45^430^7
+289 ;;^UTILITY(U,$J,358.3,8902,1,0)
+290 ;;=^358.31IA^4^2
+291 ;;^UTILITY(U,$J,358.3,8902,1,3,0)
+292 ;;=3^Nonrhematic Mitral Valve Stenosis
+293 ;;^UTILITY(U,$J,358.3,8902,1,4,0)
+294 ;;=4^I34.2
+295 ;;^UTILITY(U,$J,358.3,8902,2)
+296 ;;=^5007171
+297 ;;^UTILITY(U,$J,358.3,8903,0)
+298 ;;=I35.0^^45^430^10
+299 ;;^UTILITY(U,$J,358.3,8903,1,0)
+300 ;;=^358.31IA^4^2
+301 ;;^UTILITY(U,$J,358.3,8903,1,3,0)
+302 ;;=3^Nonrheumatic Aortic Valve Stenosis
+303 ;;^UTILITY(U,$J,358.3,8903,1,4,0)
+304 ;;=4^I35.0
+305 ;;^UTILITY(U,$J,358.3,8903,2)
+306 ;;=^5007174
+307 ;;^UTILITY(U,$J,358.3,8904,0)
+308 ;;=I35.1^^45^430^9
+309 ;;^UTILITY(U,$J,358.3,8904,1,0)
+310 ;;=^358.31IA^4^2
+311 ;;^UTILITY(U,$J,358.3,8904,1,3,0)
+312 ;;=3^Nonrheumatic Aortic Valve Insufficiency
+313 ;;^UTILITY(U,$J,358.3,8904,1,4,0)
+314 ;;=4^I35.1
+315 ;;^UTILITY(U,$J,358.3,8904,2)
+316 ;;=^5007175
+317 ;;^UTILITY(U,$J,358.3,8905,0)
+318 ;;=I35.2^^45^430^11
+319 ;;^UTILITY(U,$J,358.3,8905,1,0)
+320 ;;=^358.31IA^4^2
+321 ;;^UTILITY(U,$J,358.3,8905,1,3,0)
+322 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
+323 ;;^UTILITY(U,$J,358.3,8905,1,4,0)
+324 ;;=4^I35.2
+325 ;;^UTILITY(U,$J,358.3,8905,2)
+326 ;;=^5007176
+327 ;;^UTILITY(U,$J,358.3,8906,0)
+328 ;;=I35.9^^45^430^8
+329 ;;^UTILITY(U,$J,358.3,8906,1,0)
+330 ;;=^358.31IA^4^2
+331 ;;^UTILITY(U,$J,358.3,8906,1,3,0)
+332 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
+333 ;;^UTILITY(U,$J,358.3,8906,1,4,0)
+334 ;;=4^I35.9
+335 ;;^UTILITY(U,$J,358.3,8906,2)
+336 ;;=^5007178
+337 ;;^UTILITY(U,$J,358.3,8907,0)
+338 ;;=I38.^^45^430^4
+339 ;;^UTILITY(U,$J,358.3,8907,1,0)
+340 ;;=^358.31IA^4^2
+341 ;;^UTILITY(U,$J,358.3,8907,1,3,0)
+342 ;;=3^Endocarditis,Valve Unspec
+343 ;;^UTILITY(U,$J,358.3,8907,1,4,0)
+344 ;;=4^I38.
+345 ;;^UTILITY(U,$J,358.3,8907,2)
+346 ;;=^40327
+347 ;;^UTILITY(U,$J,358.3,8908,0)
+348 ;;=I05.0^^45^430^18
+349 ;;^UTILITY(U,$J,358.3,8908,1,0)
+350 ;;=^358.31IA^4^2
+351 ;;^UTILITY(U,$J,358.3,8908,1,3,0)
+352 ;;=3^Rheumatic Mitral Stenosis
+353 ;;^UTILITY(U,$J,358.3,8908,1,4,0)
+354 ;;=4^I05.0
+355 ;;^UTILITY(U,$J,358.3,8908,2)
+356 ;;=^5007041
+357 ;;^UTILITY(U,$J,358.3,8909,0)
+358 ;;=I05.8^^45^430^19
+359 ;;^UTILITY(U,$J,358.3,8909,1,0)
+360 ;;=^358.31IA^4^2
+361 ;;^UTILITY(U,$J,358.3,8909,1,3,0)
+362 ;;=3^Rheumatic Mitral Valve Disease NEC
+363 ;;^UTILITY(U,$J,358.3,8909,1,4,0)
+364 ;;=4^I05.8
+365 ;;^UTILITY(U,$J,358.3,8909,2)
+366 ;;=^5007043
+367 ;;^UTILITY(U,$J,358.3,8910,0)
+368 ;;=I05.9^^45^430^20
+369 ;;^UTILITY(U,$J,358.3,8910,1,0)
+370 ;;=^358.31IA^4^2
+371 ;;^UTILITY(U,$J,358.3,8910,1,3,0)
+372 ;;=3^Rheumatic Mitral Valve Disease,Unspec
+373 ;;^UTILITY(U,$J,358.3,8910,1,4,0)
+374 ;;=4^I05.9
+375 ;;^UTILITY(U,$J,358.3,8910,2)
+376 ;;=^5007044
+377 ;;^UTILITY(U,$J,358.3,8911,0)
+378 ;;=I07.1^^45^430^21
+379 ;;^UTILITY(U,$J,358.3,8911,1,0)
+380 ;;=^358.31IA^4^2
+381 ;;^UTILITY(U,$J,358.3,8911,1,3,0)
+382 ;;=3^Rheumatic Tricuspid Insufficiency
+383 ;;^UTILITY(U,$J,358.3,8911,1,4,0)
+384 ;;=4^I07.1
+385 ;;^UTILITY(U,$J,358.3,8911,2)
+386 ;;=^5007048
+387 ;;^UTILITY(U,$J,358.3,8912,0)
+388 ;;=I07.9^^45^430^22
+389 ;;^UTILITY(U,$J,358.3,8912,1,0)
+390 ;;=^358.31IA^4^2
+391 ;;^UTILITY(U,$J,358.3,8912,1,3,0)
+392 ;;=3^Rheumatic Tricuspid Valve Disease,Unspec
+393 ;;^UTILITY(U,$J,358.3,8912,1,4,0)
+394 ;;=4^I07.9
+395 ;;^UTILITY(U,$J,358.3,8912,2)
+396 ;;=^5007051
+397 ;;^UTILITY(U,$J,358.3,8913,0)
+398 ;;=I08.0^^45^430^16
+399 ;;^UTILITY(U,$J,358.3,8913,1,0)
+400 ;;=^358.31IA^4^2
+401 ;;^UTILITY(U,$J,358.3,8913,1,3,0)
+402 ;;=3^Rheumatic Disorders of Mitral & Aortic Valves
+403 ;;^UTILITY(U,$J,358.3,8913,1,4,0)
+404 ;;=4^I08.0
+405 ;;^UTILITY(U,$J,358.3,8913,2)
+406 ;;=^5007052
+407 ;;^UTILITY(U,$J,358.3,8914,0)
+408 ;;=I09.89^^45^430^17
+409 ;;^UTILITY(U,$J,358.3,8914,1,0)
+410 ;;=^358.31IA^4^2
+411 ;;^UTILITY(U,$J,358.3,8914,1,3,0)
+412 ;;=3^Rheumatic Heart Diseases NEC
+413 ;;^UTILITY(U,$J,358.3,8914,1,4,0)
+414 ;;=4^I09.89
+415 ;;^UTILITY(U,$J,358.3,8914,2)
+416 ;;=^5007060
+417 ;;^UTILITY(U,$J,358.3,8915,0)
+418 ;;=I47.1^^45^430^24
+419 ;;^UTILITY(U,$J,358.3,8915,1,0)
+420 ;;=^358.31IA^4^2
+421 ;;^UTILITY(U,$J,358.3,8915,1,3,0)
+422 ;;=3^Supraventricular Tachycardia
+423 ;;^UTILITY(U,$J,358.3,8915,1,4,0)
+424 ;;=4^I47.1
+425 ;;^UTILITY(U,$J,358.3,8915,2)
+426 ;;=^5007223
+427 ;;^UTILITY(U,$J,358.3,8916,0)
+428 ;;=I48.0^^45^430^15
+429 ;;^UTILITY(U,$J,358.3,8916,1,0)
+430 ;;=^358.31IA^4^2
+431 ;;^UTILITY(U,$J,358.3,8916,1,3,0)
+432 ;;=3^Paroxysmal Atrial Fibrillation
+433 ;;^UTILITY(U,$J,358.3,8916,1,4,0)
+434 ;;=4^I48.0
+435 ;;^UTILITY(U,$J,358.3,8916,2)
+436 ;;=^90473
+437 ;;^UTILITY(U,$J,358.3,8917,0)
+438 ;;=I49.5^^45^430^23
+439 ;;^UTILITY(U,$J,358.3,8917,1,0)
+440 ;;=^358.31IA^4^2
+441 ;;^UTILITY(U,$J,358.3,8917,1,3,0)
+442 ;;=3^Sick Sinus Syndrome
+443 ;;^UTILITY(U,$J,358.3,8917,1,4,0)
+444 ;;=4^I49.5
+445 ;;^UTILITY(U,$J,358.3,8917,2)
+446 ;;=^110404
+447 ;;^UTILITY(U,$J,358.3,8918,0)
+448 ;;=I49.8^^45^430^3
+449 ;;^UTILITY(U,$J,358.3,8918,1,0)
+450 ;;=^358.31IA^4^2
+451 ;;^UTILITY(U,$J,358.3,8918,1,3,0)
+452 ;;=3^Cardiac Arrhythmias
+453 ;;^UTILITY(U,$J,358.3,8918,1,4,0)
+454 ;;=4^I49.8
+455 ;;^UTILITY(U,$J,358.3,8918,2)
+456 ;;=^5007236
+457 ;;^UTILITY(U,$J,358.3,8919,0)
+458 ;;=I49.9^^45^430^2
+459 ;;^UTILITY(U,$J,358.3,8919,1,0)
+460 ;;=^358.31IA^4^2
+461 ;;^UTILITY(U,$J,358.3,8919,1,3,0)
+462 ;;=3^Cardiac Arrhythmia,Unspec
+463 ;;^UTILITY(U,$J,358.3,8919,1,4,0)
+464 ;;=4^I49.9
+465 ;;^UTILITY(U,$J,358.3,8919,2)
+466 ;;=^5007237
+467 ;;^UTILITY(U,$J,358.3,8920,0)
+468 ;;=R00.1^^45^430^1
+469 ;;^UTILITY(U,$J,358.3,8920,1,0)
+470 ;;=^358.31IA^4^2
+471 ;;^UTILITY(U,$J,358.3,8920,1,3,0)
+472 ;;=3^Bradycardia,Unspec
+473 ;;^UTILITY(U,$J,358.3,8920,1,4,0)
+474 ;;=4^R00.1
+475 ;;^UTILITY(U,$J,358.3,8920,2)
+476 ;;=^5019164
+477 ;;^UTILITY(U,$J,358.3,8921,0)
+478 ;;=I34.1^^45^430^14
+479 ;;^UTILITY(U,$J,358.3,8921,1,0)
+480 ;;=^358.31IA^4^2
+481 ;;^UTILITY(U,$J,358.3,8921,1,3,0)
+482 ;;=3^Nonrheumatic Mitral Valve Prolapse
+483 ;;^UTILITY(U,$J,358.3,8921,1,4,0)
+484 ;;=4^I34.1
+485 ;;^UTILITY(U,$J,358.3,8921,2)
+486 ;;=^5007170
+487 ;;^UTILITY(U,$J,358.3,8922,0)
+488 ;;=D68.4^^45^431^1
+489 ;;^UTILITY(U,$J,358.3,8922,1,0)
+490 ;;=^358.31IA^4^2
+491 ;;^UTILITY(U,$J,358.3,8922,1,3,0)
+492 ;;=3^Acquired Coagulation Factor Deficiency
+493 ;;^UTILITY(U,$J,358.3,8922,1,4,0)
+494 ;;=4^D68.4
+495 ;;^UTILITY(U,$J,358.3,8922,2)
+496 ;;=^2235
+497 ;;^UTILITY(U,$J,358.3,8923,0)
+498 ;;=D59.9^^45^431^2
+499 ;;^UTILITY(U,$J,358.3,8923,1,0)
+500 ;;=^358.31IA^4^2
+501 ;;^UTILITY(U,$J,358.3,8923,1,3,0)
+502 ;;=3^Acquired Hemolytic Anemia,Unspec
+503 ;;^UTILITY(U,$J,358.3,8923,1,4,0)
+504 ;;=4^D59.9
+505 ;;^UTILITY(U,$J,358.3,8923,2)
+506 ;;=^5002330
+507 ;;^UTILITY(U,$J,358.3,8924,0)
+508 ;;=C91.00^^45^431^5
+509 ;;^UTILITY(U,$J,358.3,8924,1,0)
+510 ;;=^358.31IA^4^2
+511 ;;^UTILITY(U,$J,358.3,8924,1,3,0)
+512 ;;=3^Acute Lymphoblastic Leukemia,Not in Remission
+513 ;;^UTILITY(U,$J,358.3,8924,1,4,0)
+514 ;;=4^C91.00
+515 ;;^UTILITY(U,$J,358.3,8924,2)
+516 ;;=^5001762
+517 ;;^UTILITY(U,$J,358.3,8925,0)
+518 ;;=C91.01^^45^431^4
+519 ;;^UTILITY(U,$J,358.3,8925,1,0)
+520 ;;=^358.31IA^4^2
+521 ;;^UTILITY(U,$J,358.3,8925,1,3,0)
+522 ;;=3^Acute Lymphoblastic Leukemia,In Remission
+523 ;;^UTILITY(U,$J,358.3,8925,1,4,0)
+524 ;;=4^C91.01
+525 ;;^UTILITY(U,$J,358.3,8925,2)
+526 ;;=^5001763
+527 ;;^UTILITY(U,$J,358.3,8926,0)
+528 ;;=C92.01^^45^431^7
+529 ;;^UTILITY(U,$J,358.3,8926,1,0)
+530 ;;=^358.31IA^4^2
+531 ;;^UTILITY(U,$J,358.3,8926,1,3,0)
+532 ;;=3^Acute Myeloblastic Leukemia,In Remission
+533 ;;^UTILITY(U,$J,358.3,8926,1,4,0)
+534 ;;=4^C92.01
+535 ;;^UTILITY(U,$J,358.3,8926,2)
+536 ;;=^5001790
+537 ;;^UTILITY(U,$J,358.3,8927,0)
+538 ;;=C92.00^^45^431^8
+539 ;;^UTILITY(U,$J,358.3,8927,1,0)
+540 ;;=^358.31IA^4^2
+541 ;;^UTILITY(U,$J,358.3,8927,1,3,0)
+542 ;;=3^Acute Myeloblastic Leukemia,Not in Remission
+543 ;;^UTILITY(U,$J,358.3,8927,1,4,0)
+544 ;;=4^C92.00
+545 ;;^UTILITY(U,$J,358.3,8927,2)
+546 ;;=^5001789
+547 ;;^UTILITY(U,$J,358.3,8928,0)
+548 ;;=C92.61^^45^431^9
+549 ;;^UTILITY(U,$J,358.3,8928,1,0)
+550 ;;=^358.31IA^4^2
+551 ;;^UTILITY(U,$J,358.3,8928,1,3,0)
+552 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,In Remission
+553 ;;^UTILITY(U,$J,358.3,8928,1,4,0)
+554 ;;=4^C92.61
+555 ;;^UTILITY(U,$J,358.3,8928,2)
+556 ;;=^5001808
+557 ;;^UTILITY(U,$J,358.3,8929,0)
+558 ;;=C92.60^^45^431^10
+559 ;;^UTILITY(U,$J,358.3,8929,1,0)
+560 ;;=^358.31IA^4^2
+561 ;;^UTILITY(U,$J,358.3,8929,1,3,0)
+562 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,Not in Remission
+563 ;;^UTILITY(U,$J,358.3,8929,1,4,0)
+564 ;;=4^C92.60
+565 ;;^UTILITY(U,$J,358.3,8929,2)
+566 ;;=^5001807
+567 ;;^UTILITY(U,$J,358.3,8930,0)
+568 ;;=C92.A1^^45^431^11
+569 ;;^UTILITY(U,$J,358.3,8930,1,0)
+570 ;;=^358.31IA^4^2
+571 ;;^UTILITY(U,$J,358.3,8930,1,3,0)
+572 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,In Remission
+573 ;;^UTILITY(U,$J,358.3,8930,1,4,0)
+574 ;;=4^C92.A1
+575 ;;^UTILITY(U,$J,358.3,8930,2)
+576 ;;=^5001814
+577 ;;^UTILITY(U,$J,358.3,8931,0)
+578 ;;=C92.A0^^45^431^12
+579 ;;^UTILITY(U,$J,358.3,8931,1,0)
+580 ;;=^358.31IA^4^2
+581 ;;^UTILITY(U,$J,358.3,8931,1,3,0)
+582 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,Not in Remission
+583 ;;^UTILITY(U,$J,358.3,8931,1,4,0)
+584 ;;=4^C92.A0
+585 ;;^UTILITY(U,$J,358.3,8931,2)
+586 ;;=^5001813
+587 ;;^UTILITY(U,$J,358.3,8932,0)
+588 ;;=C92.51^^45^431^13
+589 ;;^UTILITY(U,$J,358.3,8932,1,0)
+590 ;;=^358.31IA^4^2
+591 ;;^UTILITY(U,$J,358.3,8932,1,3,0)
+592 ;;=3^Acute Myelomonocytic Leukemia,In Remission
+593 ;;^UTILITY(U,$J,358.3,8932,1,4,0)
+594 ;;=4^C92.51
+595 ;;^UTILITY(U,$J,358.3,8932,2)
+596 ;;=^5001805
+597 ;;^UTILITY(U,$J,358.3,8933,0)
+598 ;;=C92.50^^45^431^14
+599 ;;^UTILITY(U,$J,358.3,8933,1,0)
+600 ;;=^358.31IA^4^2
+601 ;;^UTILITY(U,$J,358.3,8933,1,3,0)
+602 ;;=3^Acute Myelomonocytic Leukemia,Not in Remission
+603 ;;^UTILITY(U,$J,358.3,8933,1,4,0)
+604 ;;=4^C92.50
+605 ;;^UTILITY(U,$J,358.3,8933,2)
+606 ;;=^5001804
+607 ;;^UTILITY(U,$J,358.3,8934,0)
+608 ;;=C94.40^^45^431^17
+609 ;;^UTILITY(U,$J,358.3,8934,1,0)
+610 ;;=^358.31IA^4^2
+611 ;;^UTILITY(U,$J,358.3,8934,1,3,0)
+612 ;;=3^Acute Panmyelosis w/ Myelofibrosis,Not in Remission
+613 ;;^UTILITY(U,$J,358.3,8934,1,4,0)
+614 ;;=4^C94.40
+615 ;;^UTILITY(U,$J,358.3,8934,2)
+616 ;;=^5001843
+617 ;;^UTILITY(U,$J,358.3,8935,0)
+618 ;;=C94.42^^45^431^15
+619 ;;^UTILITY(U,$J,358.3,8935,1,0)
+620 ;;=^358.31IA^4^2
+621 ;;^UTILITY(U,$J,358.3,8935,1,3,0)
+622 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Relapse
+623 ;;^UTILITY(U,$J,358.3,8935,1,4,0)
+624 ;;=4^C94.42
+625 ;;^UTILITY(U,$J,358.3,8935,2)
+626 ;;=^5001845
+627 ;;^UTILITY(U,$J,358.3,8936,0)
+628 ;;=C94.41^^45^431^16
+629 ;;^UTILITY(U,$J,358.3,8936,1,0)
+630 ;;=^358.31IA^4^2
+631 ;;^UTILITY(U,$J,358.3,8936,1,3,0)
+632 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Remission
+633 ;;^UTILITY(U,$J,358.3,8936,1,4,0)
+634 ;;=4^C94.41
+635 ;;^UTILITY(U,$J,358.3,8936,2)
+636 ;;=^5001844
+637 ;;^UTILITY(U,$J,358.3,8937,0)
+638 ;;=D62.^^45^431^18
+639 ;;^UTILITY(U,$J,358.3,8937,1,0)
+640 ;;=^358.31IA^4^2
+641 ;;^UTILITY(U,$J,358.3,8937,1,3,0)
+642 ;;=3^Acute Posthemorrhagic Anemia
+643 ;;^UTILITY(U,$J,358.3,8937,1,4,0)
+644 ;;=4^D62.
+645 ;;^UTILITY(U,$J,358.3,8937,2)
+646 ;;=^267986
+647 ;;^UTILITY(U,$J,358.3,8938,0)
+648 ;;=C92.41^^45^431^19
+649 ;;^UTILITY(U,$J,358.3,8938,1,0)
+650 ;;=^358.31IA^4^2
+651 ;;^UTILITY(U,$J,358.3,8938,1,3,0)
+652 ;;=3^Acute Promyelocytic Leukemia,In Remission
+653 ;;^UTILITY(U,$J,358.3,8938,1,4,0)
+654 ;;=4^C92.41
+655 ;;^UTILITY(U,$J,358.3,8938,2)
+656 ;;=^5001802
+657 ;;^UTILITY(U,$J,358.3,8939,0)
+658 ;;=C92.40^^45^431^20
+659 ;;^UTILITY(U,$J,358.3,8939,1,0)
+660 ;;=^358.31IA^4^2
+661 ;;^UTILITY(U,$J,358.3,8939,1,3,0)
+662 ;;=3^Acute Promyelocytic Leukemia,Not in Remission
+663 ;;^UTILITY(U,$J,358.3,8939,1,4,0)
+664 ;;=4^C92.40
+665 ;;^UTILITY(U,$J,358.3,8939,2)
+666 ;;=^5001801
+667 ;;^UTILITY(U,$J,358.3,8940,0)
+668 ;;=D56.0^^45^431^21
+669 ;;^UTILITY(U,$J,358.3,8940,1,0)
+670 ;;=^358.31IA^4^2
+671 ;;^UTILITY(U,$J,358.3,8940,1,3,0)
+672 ;;=3^Alpha Thalassemia
+673 ;;^UTILITY(U,$J,358.3,8940,1,4,0)
+674 ;;=4^D56.0
+675 ;;^UTILITY(U,$J,358.3,8940,2)
+676 ;;=^340494
+677 ;;^UTILITY(U,$J,358.3,8941,0)
+678 ;;=D63.1^^45^431^23
+679 ;;^UTILITY(U,$J,358.3,8941,1,0)
+680 ;;=^358.31IA^4^2
+681 ;;^UTILITY(U,$J,358.3,8941,1,3,0)
+682 ;;=3^Anemia in Chronic Kidney Disease
+683 ;;^UTILITY(U,$J,358.3,8941,1,4,0)
+684 ;;=4^D63.1
+685 ;;^UTILITY(U,$J,358.3,8941,2)
+686 ;;=^332908
+687 ;;^UTILITY(U,$J,358.3,8942,0)
+688 ;;=D63.0^^45^431^24
+689 ;;^UTILITY(U,$J,358.3,8942,1,0)
+690 ;;=^358.31IA^4^2
+691 ;;^UTILITY(U,$J,358.3,8942,1,3,0)
+692 ;;=3^Anemia in Neoplastic Disease
